Clover Health Investments Corp (CLOV) with a beta value of 1.94 appears to be a promising investment opportunity.

Clover Health Investments Corp (NASDAQ: CLOV) kicked off on Monday, down -0.54% from the previous trading day, before settling in for the closing price of $3.68. Over the past 52 weeks, CLOV has traded in a range of $0.61-$4.87.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

During the last 5-year period, the sales growth of Healthcare Sector giant was 39.19%. While this was happening, its average annual earnings per share was recorded -80.25%. With a float of $383.18 million, this company’s outstanding shares have now reached $395.74 million.

Let’s determine the extent of company efficiency that accounts for 570 employees. In terms of profitability, gross margin is 26.61%, operating margin of -3.34%, and the pretax margin is -3.37%.

Clover Health Investments Corp (CLOV) Breakdown of a Key Holders of the stock

Our next focus will be how large-scale investors are participating in this stock of the Healthcare Plans Industry. The insider ownership of Clover Health Investments Corp is 25.00%, while institutional ownership is 18.20%. The most recent insider transaction that took place on Mar 07 ’25, was worth 722,000. In this transaction Director of this company sold 200,000 shares at a rate of $3.61, taking the stock ownership to the 273,227 shares. Before that another transaction happened on Mar 06 ’25, when Company’s CEO of Home Care sold 75,000 for $3.68, making the entire transaction worth $276,000. This insider now owns 2,418,151 shares in total.

Clover Health Investments Corp (CLOV) Recent Fiscal highlights

Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.0 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around -80.25% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 40.98% during the next five years compared to -237.67% drop over the previous five years of trading.

Clover Health Investments Corp (NASDAQ: CLOV) Trading Performance Indicators

Take a look at Clover Health Investments Corp’s (CLOV) current performance indicators. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.36. Likewise, its price to free cash flow for the trailing twelve months is 56.17.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.09, a number that is poised to hit -0.04 in the next quarter and is forecasted to reach -0.10 in one year’s time.

Technical Analysis of Clover Health Investments Corp (CLOV)

Looking closely at Clover Health Investments Corp (NASDAQ: CLOV), its last 5-days average volume was 7.87 million, which is a jump from its year-to-date volume of 6.25 million. As of the previous 9 days, the stock’s Stochastic %D was 87.00%. Additionally, its Average True Range was 0.25.

During the past 100 days, Clover Health Investments Corp’s (CLOV) raw stochastic average was set at 41.55%, which indicates a significant decrease from 78.18% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 51.89% in the past 14 days, which was higher than the 50.56% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $3.91, while its 200-day Moving Average is $3.27. However, in the short run, Clover Health Investments Corp’s stock first resistance to watch stands at $3.77. Second resistance stands at $3.88. The third major resistance level sits at $3.98. If the price goes on to break the first support level at $3.56, it is likely to go to the next support level at $3.46. Now, if the price goes above the second support level, the third support stands at $3.35.

Clover Health Investments Corp (NASDAQ: CLOV) Key Stats

The company with the Market Capitalisation of 1.87 billion has total of 510,907K Shares Outstanding. Its annual sales at the moment are 1,371 M in contrast with the sum of -43,010 K annual income. Company’s last quarter sales were recorded 336,960 K and last quarter income was -22,090 K.